|
|
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCD23 antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismEPO receptor agonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Biogen (Denmark) A/S
0 Patents (Medical) associated with Biogen (Denmark) A/S
100 Deals associated with Biogen (Denmark) A/S
100 Translational Medicine associated with Biogen (Denmark) A/S